armata investors

Investors Overview

Stock Quote: ARMP

NYSE AmericanARMP
Price

$

Change

High

$00.00

View Details

Minimum 15 minutes delayed.

Latest Press Releases
Jan 27, 2021
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and...

Dec 9, 2020
Armata Pharmaceuticals Announces the Addition of Robin C. Kramer to its Board of Directors

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant and...

Nov 12, 2020
Armata Pharmaceuticals Announces Third Quarter 2020 Results and Provides General Corporate Update

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for...